TherapeuticsMD (TXMD) Research Hub

TherapeuticsMD (TXMD) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 2.16 USD (+1.89%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 131.17, market cap 0.02B. This hub links to the full technical, earnings and options research available for TXMD.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Drug Manufacturers - Specialty & Generic)
ExchangeNASDAQ, US
Last close2.16 USD (+1.89%)
52-week range1.91 USD – 2.42 USD
Trend regimeRange
14-day RSI56.5 (Bullish)
Trailing P/E131.17
Market cap0.02B
Dividend yield0.00%
Next earnings2026-08-17

Available research for TXMD

Earnings

TXMD earnings: next report 2026-08-17, real EPS beat/miss history, analyst consensus Buy, P/E 131.17. Updated 2026-07-23.

Options: Covered Call

Covered Call on TXMD: how it works, illustrative setup around the real 2.16 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on TXMD: how it works, illustrative setup around the real 2.16 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on TXMD: how it works, illustrative setup around the real 2.16 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

TXMD technical analysis: range, last 2.16 USD, RSI 56.5, 52w range 1.91 USD–2.42 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is TXMD in?

TherapeuticsMD (TXMD) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, US.

Is TXMD in an uptrend or downtrend?

As of 2026-09-11, TXMD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is TXMD's trailing P/E ratio?

TXMD's trailing P/E is 131.17, with a market cap of 0.02B. See the earnings research page for full valuation detail.

When does TXMD next report earnings?

TXMD is next scheduled to report earnings on 2026-08-17, with a consensus EPS estimate of -5.5 USD.